Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹10.65
Market cap: ₹238.8 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-292.9 Cr
P/E (TTM): -1.0×Sector 47.4×
Promoter holding: 51.84%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 4 Financial Results 4 Merger & Restructuring 3 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

10 Aug 2026 20:44 IST BSE

Board Meeting Date

Nectar Lifesciences Board Meeting Date

Nectar Lifesciences Ltd. has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗

25 May 2026 13:22 IST BSE

Board Meeting Date

Nectar Lifesciences Board Meeting Date

Nectar Lifesciences Ltd scheduled a board meeting for May 30, 2026. Directors will consider and approve audited financial results for the 2025-26 fiscal year.

Read the filing ↗